Harvard Bioscience, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -0.3% | -0.2% | -0.2% |
| FY2022 | -13.2% | -8.3% | -6.5% |
| FY2023 | -4.7% | -3.3% | -2.5% |
| FY2024 | -19.6% | -19.6% | -9.8% |
| FY2025 | -412.8% | -114.3% | -70.8% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -0.3% | -0.2% | -0.2% |
| FY2022 | -13.2% | -8.3% | -6.5% |
| FY2023 | -4.7% | -3.3% | -2.5% |
| FY2024 | -19.6% | -19.6% | -9.8% |
| FY2025 | -412.8% | -114.3% | -70.8% |